Shaanxi Meibang Pharmaceutical Group (605033.SH) terminates the issue of convertible bonds and withdraws the application documents.

Shaanxi Meibang Pharmaceutical Group (605033.SH) announced that since the company applied to issue convertible corporate bonds to unspecified entities, the company has been actively promoting related work with relevant intermediary institutions. However, after comprehensive consideration of business performance, market conditions, and other factors, and after repeated careful discussions with each intermediary institution, the company has decided to terminate the issuance of convertible corporate bonds to unspecified entities this time.